Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
Conclusion: The SFI treatment efficiently extended the overall survival and improved the pathological manifestations of the brain via alleviating the OS injury and activating the Nrf2 pathway in the animal model of ALS, which made SFI a potentially promising candidate for ALS treatment.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: ALS | Antidoxidants | Brain | China Health | Drugs & Pharmacology | Herbs | Motor Neurone Disease | Neurology